Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 416-250-2 | CAS number: 84632-59-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Pigment Orange 73 showed no adverse effects at the limit dose of 1000 mg/kg bw upon subacute gavage dosing in rats (OECD 407, GLP) (RCC Ltd 1994).
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Link to relevant study records
- Endpoint:
- short-term repeated dose toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1993-12-21 - 1994-07-12
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Guideline study (OECD TG 407) performed under GLP with deficiencies to current guidelines: Wet weighing of coagulating glands, epididymides, prostate and seminal vesicles was not performed. No FOB is part of the study (a subchronic study is not available). However, wet weights of thyroid and ovaries were determined and histopathological endpoints for the detection of endocrine effects were included in this reliable study.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 407 (Repeated Dose 28-Day Oral Toxicity Study in Rodents)
- Version / remarks:
- adopted on 12th May 1981
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.7 (Repeated Dose (28 Days) Toxicity (Oral))
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Japanese Chemical Substance Law (1987) according to the notification of December 9, 1986 by EA, Environmental Agency (No. 700); MHW, Ministry of Health and Welfare (No. 1039) and MITI, Ministry of International Trade and Industry (No. 1014).
- Deviations:
- not specified
- GLP compliance:
- yes
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: BRL Ltd, Füllinsdorf, Switzerland
- Age at study initiation: ca. 6 weeks old
- Body weight range at acclimatization: Males: 142.5 – 157.4 g, females: 115.3 – 129.1 g
- Housing: Individually in Makrolon type-3 cages with autoclaved standard softwood bedding
- Diet: Pelleted standard Kliba 343 rat maintenance diet (Klingentalmuehle AG, Kaiseraugst, Switzerland), ad libitum
- Water: Community tap-water from Füllinsdorf, ad libitum
- Acclimation period: 6 days under laboratory conditions after veterinary examination
ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 3 °C
- Humidity: 40 - 70 %
- Air changes: 10 - 15 changes/hour
- Photoperiod: 12 hours fluorescent light/12 hours dark, music during the light period
IN-LIFE DATES:
- From: 1993-12-29 To: 1994-02-09 - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- PREPARATION OF DOSING SOLUTIONS:
The test item was weighed into a glass beaker on a tared Mettler balance and the vehicle was added. The mixtures (w/v) were prepared using a homogenizer. Homogeneity of the test item in the vehicle was maintained during treatment using a magnetic stirrer.
VEHICLE
- Justification for use and choice of vehicle: standard vehicle for studies of this type
- Concentration in vehicle: 5, 20 or 100 mg/mL
- Amount of vehicle: dose volume of 10 mL/kg bw - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Samples of dose formulations of the pretest and of the test were analysed to check homogeneity, concentration and stability.
- Duration of treatment / exposure:
- 28 days
- Frequency of treatment:
- Once daily
- Remarks:
- Doses / Concentrations:
0, 50, 200, 1000 mg/kg bw/d
Basis:
actual ingested - No. of animals per sex per dose:
- - 5 animals/sex/dose level (main study)
- additional 5 animals/sex at 0 and 1000 mg/kg bw/d (recovery assessment) - Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: Based upon the results of a non-GLP 5-day dose range-finding study (RCC Study Number 360641) in which the test item was administered orally by gavage to rats.
- Post exposure recovery period in satellite groups: 14 days - Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: Once daily
- Mortality/Viability: Once daily
DETAILED CLINICAL OBSERVATIONS: No
BODY WEIGHT: Yes
- On day 1 of the pretest, on days 1, 8, 15, 22 and 28 of the treatment period and on days 1, 8 and 14 of the recovery period.
- Terminal body weights were recorded at necropsy.
FOOD CONSUMPTION: Yes
- Once during the acclimatization period and weekly thereafter.
OPHTHALMOSCOPIC EXAMINATION: Yes
- Time schedule: at 4 weeks (all animals) and at 6 weeks (all recovery animals)
- Heine BETA 200 Ophthalmoscope (Eisenhut Vet. AG, 4123 Allschwil, Switzerland)
HAEMATOLOGY: Yes
- Time schedule for collection of blood: after 4 weeks and 6 weeks
- Anaesthetic used for blood collection: Yes (ether)
- Animals fasted: Yes, for approximately 18 hours before blood sampling
- How many animals: all animals
- Parameters examined: Erythrocyte count, Hemoglobin, Hematocrit, Mean corpuscular volume, Mean corpuscular hemoglobin, Mean corpuscular hemoglobin concentration, Platelet count, Reticulocyte count, Reticulocyte fluorescence ratios, Nucleated erythrocytes (normoblasts), Heinz bodies, Methemoglobin, Total leukocyte count, Differential leukocyte count, Red blood cell morphology, Thromboplastin time (=prothrombin time), Activated partial thromboplastin time.
- Other: Blood samples were collected early in the working day to reduce biological variation caused by circadian rhythms. Blood samples were drawn from the retro-orbital plexus using a microhematocrit glass capillary tube.
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: after 4 weeks and 6 weeks
- Metabolism cages used for collection of urine: yes
- Parameters examined: Glucose, Urea, Creatinine, Uric acid, Bilirubin (total), Cholesterol (total), Triglycerides, Phospholipids, Aspartate aminotransferase, Alanine aminotransferase, Lactate dehydrogenase, Creatine kinase, Alkaline phosphatase, Gamma-glutamyl transferase, Calcium, Phosphorus, Sodium, Potassium, Chloride, Albumin, Protein (total), Globulin, Albumin/Globulin ratio
URINALYSIS: Yes
- Time schedule for collection of urine: after 4 weeks and 6 weeks
- Animals fasted: Yes, urine was collected during the 18-hour fasting period into a specimen vial
- Parameters examined: Volume (18-hour), Specific gravity, Osmolality, Color, Appearance, pH, Protein, Glucose, Ketone, Bilirubin, Blood, Nitrite, Urobilinogen, Urine sediment.
NEUROBEHAVIOURAL EXAMINATION: No - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes, after 4 weeks and after 6 weeks
All animals were weighed and necropsied. Descriptions of all macroscopic abnormalities were recorded. All animals surviving to scheduled necropsy and all moribund animals were anesthetized by intraperitoneal injection of sodium pentobarbitone (NARCOREN) and killed by exsanguination.
The following organ weights were recorded on the scheduled dates of necropsy: adrenals, brain, heart, kidneys, liver, ovaries, pituitary, spleen, testes, thyroid including parathyroid gland. The organ to terminal body weight ratios as well as organ to brain weight ratios were determined. The determination of the terminal body weight was performed immediately prior to necropsy.
All organ and tissue samples, as defined under Histopathology, were processed, embedded and cut at an approximate thickness of 2 to 4 micrometers, and stained with hematoxylin and eosin.
HISTOPATHOLOGY: Yes
Slides of all organs and tissues marked with an asteriks which were collected at scheduled sacrifice from the animals of control and high-dose groups were examined; samples of the following tissues and organs were collected from all animals at necropsy and fixed in neutral phosphate buffered 4 % formaldehyde solution: adrenals*, aorta, bone (sternum, femur), bone marrow (sternum, femur), brain, cecum, colon, duodenum, epididymides, esophagus, eyes with optic nerve, harderian gland, femur including joint, heart*, ileum, jejunum, kidneys*, larynx, lacrimal gland, exorbital, liver*, lung infused with formalin*, lymph nodes, mandibular, mesenteric, mammary gland area, nasal cavity, ovaries, pancreas, pituitary gland, prostate gland, rectum, salivary gland, (mandibular, sublingual), seminal vesicles, sciatic nerve, skeletal muscle, skin, spinal cord, (cervical, midthoracic, lumbar), spleen*, stomach*, testes*, thymus, thyroid incl. parathyroid gland, tongue, trachea, urinary bladder infused with formalin, uterus; vagina and gross lesions. - Statistics:
- The following statistical methods were used to analyze the body weights, food consumption, organ weights and their all ratios and clinical laboratory data:
When the variables could be assumed to follow a normal distribution, the Dunnett-test (many to one t-test) based on a pooled variance estimate was applied for the comparison between the treated groups and the control groups for each sex. The Steel-test (many-one rank test) was applied when the data could not be assumed to follow a normal distribution. The Fisher's exact test was applied to the ophthalmoscopy data. - Details on results:
- Mortality/Viability and Clinical signs:
No unscheduled deaths or clinical signs of reaction to treatment were noted in all groups. At 1000 mg/kg bw/d, red faeces were noted in all animals. This finding was caused due to coloration by the test item.
Body weights:
In all dose groups (50, 200, 1000 mg/kg bw/d), the body weights of the animals were not affected by the treatment with the test item compared with controls.
Food consumption:
Up to and including the highest dose group of 1000 mg/kg bw/d, no adverse effects on the food consumption of the animals were noted.
Haematology / Clinical biochemistry /Urinalysis:
The assessment of hematological, clinical biochemical and urinalysis data indicated no changes of toxicological significance at termination of the treatment nor at the end of the treatment-free recovery period.
GROSS PATHOLOGY / HISTOPATHOLOGY:
- Organ weights: No test item related changes in organ weights were noted.
- Macroscopic and microscopic findings:
At macroscopic- as well as at histopathologic examination, there were no test item abnormal findings of toxicological relevance. At terminal necropsy of the animals sacrificed at the end of the treatment period, the red discoloration of the gastrointestinal tract was considered to be due to passive coloration by the test item. This finding was confirmed at microscopic examination of the gastrointestinal tract which revealed the presence of colored particles of the test item. - Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: No test-item related adverse effects up to and including the high dose level of 1000 mg/kg bw/d.
- Critical effects observed:
- not specified
Reference
ANALYSIS OF DOSE FORMULATIONS
Acclimatization/Pretest:
The mean concentrations of the homogeneity samples taken during acclimatization/pretest were found to be 103.0 %, 92.6 % and 100.8 % of the nominal concentrations for dose groups 2 (5 mg/mL). 3 (20 mg/mL) and 4 (100 mg/mL), respectively. The homogeneity varied in the range from -7 % to +5 % of the mean concentrations.
Administration/Test:
The mean concentrations of the homogeneity samples taken during administration/treatment were found to be 102.5 %, 102.8 % and 105.5 % of the nominal concentrations for dose groups 2 (5 mg/mL). 3 (20 mg/mL) and 4 (100 mg/mL), respectively. The homogeneity varied in the range from -7 % to +10 % of the mean concentrations.
The test item was found to be stable in corn oil at room temperature for at least two hours.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- valid without restrictions
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: inhalation - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
In the subacute toxicity study, Pigment Orange 73 was administered daily by gavage to SPF-bred Wistar rats of both sexes at dose levels of 0, 50, 200 and 1000 mg/kg body weight/day for a period of 28 days (RCC Ltd 1994). After termination of the treatment period half of the animals of the control group and of the high dose group were observed for a further 14-day treatment-free recovery period. The protocol followed OECD testing guideline 407 (adopted 1981). No unscheduled deaths or clinical signs of reaction to treatment were noted in all groups. At 1000 mg/kg, red feces were noted in all animals. This finding was caused due to the coloration by the test article. Up to and including the highest dose group of 1000 mg/kg, no adverse effects on the food consumption of the animals were noted. In all dose groups (50, 200, 1000 mg/kg), the body weights of the animals were not affected by the treatment with the test article. The assessment of hematological, clinical biochemical and urinalysis data indicated no changes of toxicological significance at termination of the treatment nor at the end of the treatment-free recovery period. No test article related changes in organ weights were noted. At macroscopic- as well as at histopathologic examination, there were no test article abnormal findings of toxicological relevance. At terminal necropsy of the animals sacrificed at the end of the treatment period, the red discoloration of the gastrointestinal tract was considered to be due to passive coloration by the test article. This finding was confirmed at microscopic examination of the gastrointestinal tract which revealed the presence of colored particles of the test article. The NOEL is 1000 mg/kg bw.
Justification for classification or non-classification
Dangerous Substance Directive (67/548/EEC)
The available studies are considered reliable and suitable for classification purposes under 67/548/EEC. As a result the substance is not considered to be classified for repeated dose toxicity under Directive 67/548/EEC, as amended for the
31st time in Directive 2009/2/EG.
Classification, Labelling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. As a result the substance is not considered to be classified for repeated dose toxicity under Regulation (EC) No. 1272/2008, as amended for the third time in Directive EC 618/2012.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.